跳转至内容
Merck
CN

K4894

Sigma-Aldrich

Kolliphor HS 188

solid

别名:

聚(乙二醇)- 嵌段 - 聚(丙二醇)- 嵌段 - 聚(乙二醇), Lutrol F68, Poloxamer 188

登录查看公司和协议定价


About This Item

CAS号:
MDL编号:
UNSPSC代码:
12161902
NACRES:
NA.75

Agency

USP/NF
meets USP testing specifications

质量水平

形式

solid

分子量

8.400 g/mol

pH值(酸碱度)

5.0-7.5(2.5% solution)

应用

sample preservation

InChI

1S/C3H6O.C2H4O/c1-3-2-4-3;1-2-3-1/h3H,2H2,1H3;1-2H2

InChI key

RVGRUAULSDPKGF-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

Poloxamer 188是一种非离子型两亲共聚物,其中心链为疏水聚氧丙烯,末端为亲水聚氧乙烯。

应用

Poloxamer 188已用作细胞解离/最小基本介质(MEM)的组分,以使用 EpCAM 抗体偶联磁珠分选肿瘤细胞。
Poloxamer 188已被用作F17培养基中的补充剂,用于培养HEK293-6E细胞。它还被用作流式细胞分析(FACS)缓冲液的组分,用作保护细胞免受流体动力损害的非离子型除垢剂。

生化/生理作用

Poloxamer 188具有细胞保护、血液流变学、抗炎、抗血栓活性。它可以维持膜屏障功能的稳定。P188 可降低表面张力和疏水细胞粘附。它还能抑制受 Fe2+ 和 H2O2 刺激的脂质过氧化。

法律信息

WGK

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

S Dhara et al.
Nature communications, 12(1), 3044-3044 (2021-05-26)
Unlike other malignancies, therapeutic options in pancreatic ductal adenocarcinoma (PDAC) are largely limited to cytotoxic chemotherapy without the benefit of molecular markers predicting response. Here we report tumor-cell-intrinsic chromatin accessibility patterns of treatment-naïve surgically resected PDAC tumors that were subsequently
S Dhara et al.
Nature communications, 12(1), 3044-3044 (2021-05-26)
Unlike other malignancies, therapeutic options in pancreatic ductal adenocarcinoma (PDAC) are largely limited to cytotoxic chemotherapy without the benefit of molecular markers predicting response. Here we report tumor-cell-intrinsic chromatin accessibility patterns of treatment-naïve surgically resected PDAC tumors that were subsequently
Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Denise Chroscinski
eLife (2015)
Antibody humanization by molecular dynamics simulations?in-silico guided selection of critical backmutations
Christian Margretter
Journal of Molecular Recognition (2016)
Martin Emanuele et al.
Drugs in R&D, 14(2), 73-83 (2014-04-12)
Poloxamer 188 (P188) is a non-ionic amphiphilic copolymer with hemorheologic, antithrombotic, anti-inflammatory, and cytoprotective properties. It potentially has clinical utility in diverse diseases, such as acute myocardial infarction, acute limb ischemia, shock, acute stroke, heart failure, and sickle cell crisis.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门